The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fallarino, F.
Right arrow Articles by Puccetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fallarino, F.
Right arrow Articles by Puccetti, P.
The Journal of Immunology, 2000, 165: 5495-5501.
Copyright © 2000 by The American Association of Immunologists

Th1 and Th2 Cell Clones to a Poorly Immunogenic Tumor Antigen Initiate CD8+ T Cell-Dependent Tumor Eradication In Vivo1

Francesca Fallarino, Ursula Grohmann, Roberta Bianchi, Carmine Vacca, Maria C. Fioretti and Paolo Puccetti2

Department of Experimental Medicine, University of Perugia, Perugia, Italy

Although CD8+ T cells play a central role as immune effectors, CD4+ T cells act to control the activation and persistence of the CD8+ T cell response in autoimmune disease, antiviral immunity, and experimental systems with immunogenic model tumor Ag. However, little information is available on the effects of CD4+ T cells on the function of endogenous CD8+ T lymphocytes recognizing authentic tumor rejection Ag with limited immunogenicity. We report here that the prophylactic or postchallenge administration of T helper Th1-type and Th2-type CD4+ clones specific for an unmutated rejection Ag (murine P815AB, resembling tumor-specific shared Ag in humans) leads to the induction of P815AB-specific reactivity in vivo and concomitant tumor destruction, with quantitative rather than qualitative differences characterizing the antitumor activity of Th1 vs Th2 cells. Because the transferred CD4+ cells lacked direct antitumor activity in vitro and required the de novo generation of P815AB-specific CD8+ T cells in vivo, these findings suggest that CD4+ lymphocytes can enhance the ability of host APC to initiate an endogenous CD8+ T cell response to authentic, poorly immunogenic tumor rejection Ag.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
K. H. Park, E. Gad, V. Goodell, Y. Dang, T. Wild, D. Higgins, P. Fintak, J. Childs, C. dela Rosa, and M. L. Disis
Insulin-like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer
Cancer Res., October 15, 2008; 68(20): 8400 - 8409.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Liu, H. S. Noh, J. Chen, J. H. Kim, L. D. Falo Jr., and Z. You
Potent Tumor-Specific Protection Ignited by Adoptively Transferred CD4+ T Cells
J. Immunol., September 15, 2008; 181(6): 4363 - 4370.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. R. Kalli, C. J. Krco, L. C. Hartmann, K. Goodman, M. J. Maurer, C. Yu, E. M. Johnson, C. L. Erskine, M. L. Disis, P. J. Wettstein, et al.
An HLA-DR-Degenerate Epitope Pool Detects Insulin-like Growth Factor Binding Protein 2-Specific Immunity in Patients with Cancer
Cancer Res., June 15, 2008; 68(12): 4893 - 4901.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Vujanovic, M. Mandic, W. C. Olson, J. M. Kirkwood, and W. J. Storkus
A Mycoplasma Peptide Elicits Heteroclitic CD4+ T Cell Responses against Tumor Antigen MAGE-A6
Clin. Cancer Res., November 15, 2007; 13(22): 6796 - 6806.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Balza, L. Mortara, F. Sassi, S. Monteghirfo, B. Carnemolla, P. Castellani, D. Neri, R. S. Accolla, L. Zardi, and L. Borsi
Targeted Delivery of Tumor Necrosis Factor-{alpha} to Tumor Vessels Induces a Therapeutic T Cell-Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin
Clin. Cancer Res., April 15, 2006; 12(8): 2575 - 2582.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Chamoto, D. Wakita, Y. Narita, Y. Zhang, D. Noguchi, H. Ohnishi, T. Iguchi, T. Sakai, H. Ikeda, and T. Nishimura
An Essential Role of Antigen-Presenting Cell/T-Helper Type 1 Cell-Cell Interactions in Draining Lymph Node during Complete Eradication of Class II-Negative Tumor Tissue by T-Helper Type 1 Cell Therapy
Cancer Res., February 1, 2006; 66(3): 1809 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Cannarile, F. Fallarino, M. Agostini, S. Cuzzocrea, E. Mazzon, C. Vacca, T. Genovese, G. Migliorati, E. Ayroldi, and C. Riccardi
Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines
Blood, February 1, 2006; 107(3): 1039 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol., November 1, 2005; 17(11): 1429 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S.-i. Hiraoka, N. Takeuchi, Y. Bian, H. Nakahara, M. Kogo, K. Dunussi-Joannopoulos, S. Wolf, S. Ono, and H. Fujiwara
B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors
Int. Immunol., August 1, 2005; 17(8): 1071 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Tsuji, M. Yasukawa, J. Matsuzaki, T. Ohkuri, K. Chamoto, D. Wakita, T. Azuma, H. Niiya, H. Miyoshi, K. Kuzushima, et al.
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes
Blood, July 15, 2005; 106(2): 470 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Orabona, M. L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Volpi, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti
Cutting Edge: Silencing Suppressor of Cytokine Signaling 3 Expression in Dendritic Cells Turns CD28-Ig from Immune Adjuvant to Suppressant
J. Immunol., June 1, 2005; 174(11): 6582 - 6586.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. S. D. Reid, K. She, L. Terrett, M. R. Food, J. D. Trudeau, and K. R. Schultz
CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response
Blood, May 1, 2005; 105(9): 3641 - 3647.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Yamaguchi, S.-i. Hiraoka, T. Mukai, N. Takeuchi, X.-Y. Zhou, S. Ono, M. Kogo, K. Dunussi-Joannopoulos, V. Ling, S. Wolf, et al.
Induction of Tumor Regression by Administration of B7-Ig Fusion Proteins: Mediation by Type 2 CD8+ T Cells and Dependence on IL-4 Production
J. Immunol., February 1, 2004; 172(3): 1347 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. H. Slager, M. Borghi, C. E. van der Minne, C. A. Aarnoudse, M. J. E. Havenga, P. I. Schrier, S. Osanto, and M. Griffioen
CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame
J. Immunol., February 1, 2003; 170(3): 1490 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Bronte, P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutter, et al.
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
J. Immunol., January 1, 2003; 170(1): 270 - 278.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Tatsumi, L. S. Kierstead, E. Ranieri, L. Gesualdo, F. P. Schena, J. H. Finke, R. M. Bukowski, J. Mueller-Berghaus, J. M. Kirkwood, W. W. Kwok, et al.
Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma
J. Exp. Med., September 2, 2002; 196(5): 619 - 628.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, M. C. Fioretti, and P. Puccetti
CD40 Ligand and CTLA-4 Are Reciprocally Regulated in the Th1 Cell Proliferative Response Sustained by CD8+ Dendritic Cells
J. Immunol., August 1, 2002; 169(3): 1182 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Huang, F. Li, J. R. Gordon, and J. Xiang
Synergistic Enhancement of Antitumor Immunity with Adoptively Transferred Tumor-specific CD4+ and CD8+ T Cells and Intratumoral Lymphotactin Transgene Expression
Cancer Res., April 1, 2002; 62(7): 2043 - 2051.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
F. Fallarino, C. Vacca, C. Orabona, M. L. Belladonna, R. Bianchi, B. Marshall, D. B. Keskin, A. L. Mellor, M. C. Fioretti, U. Grohmann, et al.
Functional expression of indoleamine 2,3-dioxygenase by murine CD8{alpha}+ dendritic cells
Int. Immunol., January 1, 2002; 14(1): 65 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. M. Zarour, B. Maillere, V. Brusic, K. Coval, E. Williams, S. Pouvelle-Moratille, F. Castelli, S. Land, J. Bennouna, T. Logan, et al.
NY-ESO-1 119-143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells
Cancer Res., January 1, 2002; 62(1): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Meyer zum Buschenfelde, J. Metzger, C. Hermann, N. Nicklisch, C. Peschel, and H. Bernhard
The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells
J. Immunol., August 1, 2001; 167(3): 1712 - 1719.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Grohmann, F. Fallarino, R. Bianchi, M. L. Belladonna, C. Vacca, C. Orabona, C. Uyttenhove, M. C. Fioretti, and P. Puccetti
IL-6 Inhibits the Tolerogenic Function of CD8{{alpha}}+ Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
J. Immunol., July 15, 2001; 167(2): 708 - 714.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Grohmann, M. L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Orabona, M. C. Fioretti, and P. Puccetti
Positive Regulatory Role of IL-12 in Macrophages and Modulation by IFN-{{gamma}}
J. Immunol., July 1, 2001; 167(1): 221 - 227.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Grohmann, F. Fallarino, S. Silla, R. Bianchi, M. L. Belladonna, C. Vacca, A. Micheletti, M. C. Fioretti, and P. Puccetti
CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells
J. Immunol., January 1, 2001; 166(1): 277 - 283.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.